Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Navco Pharmaceuticals Inc

NAV.V ✓ COMPLIANT ☆ Track — members

TSX Venture · Consumer Non-Cyclicals · Personal Products ·

Canada Micro Cap Analyst: N/A

Last Close

$0.00

▲ +0.00%

Market Cap $207.32K · Vol 1.07K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$207.32K

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

50.00

Momentum

Beta

2.16

vs Market

52W High

$0.01

51.28% below

52W Low

$0.00

2.62% above

Volume

1.07K

Avg 8.19K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

89.51%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Navco Pharmaceuticals Inc (NAV.V) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does NAV.V pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

YTD

-50.00%

-83.62%

-95.00%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-57,055.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-203.17% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	57.07M

Technical Indicators

50-Day SMA	$0.00
200-Day SMA	$0.01
RSI (14)	50.00
Beta	2.16
52-Week High	$0.01
52-Week Low	$0.00

Volume Today	1.07K
Avg Daily Volume (30D)	8.19K
Relative Volume	0.13x
Volatility (10D)	0.00
Volatility (30D)	282.98
Free Float	89.51%

Analyst Consensus

N/A

Current Price $0.00

Mean Target N/A

52W Low$0.00 52W High$0.01

Current

Target

$0.00 $0.01

Current Analyst target

· 0 analysts

Identifiers

ExchangeTSX Venture

FIGIBBG00LPYCVW4

ISINCA63942R1091

CountryCanada

Sub-IndustryPersonal Products (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

PG Procter & Gamble Co +1.33% ULVR.L Unilever PLC +2.17% UL Unilever PLC +1.84% CL Colgate-Palmolive Co +1.61% HINDUNILVR.NS Hindustan Unilever Ltd +0.74%

Company Profile

Navco Pharmaceuticals Inc. is a Canada-based company. The Company is engaged in developing and commercializing products to protect against viruses, bacteria, and infectious diseases. It manufactures and researches nanotechnology products and materials using Computerized Nano-meter Algorithms (CNA). The Company's pipeline of applications is tailored to defend against microorganisms such as viruses, bacteria, fungi, and genetic manipulation tools such as clustered regularly interspaced short palindromic repeats (CRISPR). Its target markets include human health and personal skin care, household and institutional products and veterinary health. It offers multiple main product lines, namely, an aerosol spray, hand sanitizer, hand cream, and nano BioGuard-Silver. It also offers sublingual strips (the MunoStrips) infused with immune-boosting compounds to help maintain immune function and help support the body’s metabolism.